Robert G. L. Shorr is Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have made 6 open-market trades across 2 companies since 2009, most recently 2017-11-10.
CIK 0001197981
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCLI | SELL | 2015-12-16 | 2015-12-17 | $2.71 | $29K | -32.9% | -30.1% | -3.5% |
| BCLI | SELL | 2015-12-10 | 2015-12-14 | $2.64 | $28K | -32.9% | -32.9% | -7.3% |
| BCLI] | SELL | 2011-12-05 | 2011-12-07 | $0.26 | $26K | N/A | N/A | N/A |
| BCLI | SELL | 2011-11-28 | 2011-11-30 | $0.27 | $3K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2011-10-04 | 2011-10-06 | $0.31 | $61K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2009-10-16 | 2010-04-30 | $0.29 | $58K | -32.9% | +3.1% | +3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.